Jim Simons - Renaissance Technologies LLC 13F Activity & Position Changes (Q2 2024)
As of Jun 30, 2024, the Renaissance Technologies LLC portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Aug 09, 2024. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.
During Q2 2024, the filing reported:
New Buys - Abacus Life, Inc., Acumen Pharmaceuticals, Inc., Arcosa, Inc., Arcellx, Inc., Accenture plc, and 450 more
Increases - Atlantic American Corporation, , Advance Auto Parts Inc., Apple Inc., iShares MSCI All Country Asia e, and 1327 more
Reductions - Alcoa Corporation, Goldman Sachs Physical Gold ETF, Aadi Bioscience, Inc., American Airlines Group, Inc., American Assets Trust, Inc., and 1366 more
Complete Exits - NeuBase Therapeutics, AAON, Inc., ABM Industries Incorporated, Absci Corporation, ACM Research, Inc., and 544 more
These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.
| Date | Symbol | Type | Change Qty |
|---|---|---|---|
|
Q2 2024
|
64132K201
NeuBase Therapeutics
|
Sell - Position Exit |
-88,229
|
|
Q2 2024
|
AA
Alcoa Corporation
|
Sell |
-80,700
|
|
Q2 2024
|
AAAU
Goldman Sachs Physical Gold ETF
|
Sell |
-127,200
|
|
Q2 2024
|
AADI
Aadi Bioscience, Inc.
|
Sell |
-104,500
|
|
Q2 2024
|
AAL
American Airlines Group, Inc.
|
Sell |
-271,800
|
|
Q2 2024
|
AAME
Atlantic American Corporation
|
Buy |
+300
|
|
Q2 2024
|
Buy |
+58,100
|
|
|
Q2 2024
|
AAON
AAON, Inc.
|
Sell - Position Exit |
-37,635
|
|
Q2 2024
|
AAP
Advance Auto Parts Inc.
|
Buy |
+39,300
|
|
Q2 2024
|
AAPL
Apple Inc.
|
Buy |
+1,307,877
|
|
Q2 2024
|
AAT
American Assets Trust, Inc.
|
Sell |
-69,100
|
|
Q2 2024
|
AAXJ
iShares MSCI All Country Asia e
|
Buy |
+6,300
|
|
Q2 2024
|
ABBV
AbbVie Inc.
|
Buy |
+175,677
|
|
Q2 2024
|
ABCL
AbCellera Biologics Inc.
|
Buy |
+239,000
|
|
Q2 2024
|
ABEO
Abeona Therapeutics Inc.
|
Buy |
+429,456
|
|
Q2 2024
|
ABEV
Ambev S.A.
|
Buy |
+7,412,395
|
|
Q2 2024
|
Buy |
+7,400
|
|
|
Q2 2024
|
ABL
Abacus Life, Inc.
|
Buy - Position Entry |
+12,200
|
|
Q2 2024
|
ABM
ABM Industries Incorporated
|
Sell - Position Exit |
-18,500
|
|
Q2 2024
|
ABNB
Airbnb, Inc.
|
Sell |
-1,022,060
|
|
Q2 2024
|
ABOS
Acumen Pharmaceuticals, Inc.
|
Buy - Position Entry |
+338,100
|
|
Q2 2024
|
ABSI
Absci Corporation
|
Sell - Position Exit |
-130,300
|
|
Q2 2024
|
ABT
Abbott Laboratories
|
Buy |
+725,600
|
|
Q2 2024
|
AC
Associated Capital Group, Inc.
|
Buy |
+800
|
|
Q2 2024
|
ACA
Arcosa, Inc.
|
Buy - Position Entry |
+22,800
|
|
Q2 2024
|
ACAD
ACADIA Pharmaceuticals Inc.
|
Sell |
-97,800
|
|
Q2 2024
|
ACB
Aurora Cannabis Inc.
|
Sell |
-262,915
|
|
Q2 2024
|
ACCD
Accolade, Inc.
|
Buy |
+800
|
|
Q2 2024
|
ACCO
Acco Brands Corporation
|
Buy |
+91,600
|
|
Q2 2024
|
ACDC
ProFrac Holding Corp.
|
Sell |
-45,925
|
Page 1 of 124